Satoru Okada

11PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersTumour immunologyMedia industry studiesCancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 03, 2026
Prognostic significance of predicted skeletal muscle index after curative-intent resection for non-small cell lung cancer.

|Jul 10, 2026
Pathobiology of thymic epithelial tumours and the treatment strategy based on immuno-oncological characteristics: a narrative review.

|Feb 20, 2026
Nationwide trends in mediastinal tumor and myasthenia gravis surgery in Japan: a decade claims-based analysis (2014-2023).

Masamitsu Kido, Satoru Okada, Tatsuo Furuya

|Jan 23, 2026
Pulmonary metastasectomy from bone and soft tissue sarcomas: defining surgical indications at the time of second pulmonary recurrence.

Daichi Kakibuchi, Satoru Okada, Tatsuo Furuya

|Dec 03, 2025
Proteasome inhibition as a potential therapeutic target in thymic cancer.

Satoru Okada, Louisa Benter, Leon Schrell

|Nov 08, 2025
Transforming Growth Factor-β1 as a Biomarker of Malignant Behavior and PD-L1 Expression in Thymic Epithelial Tumors.

Chiaki Nakazono, Satoru Okada, So Tando

Pageof 2

Frequent Collaborators

2 joint publications

Stefan Küffer

2 joint publications

Alexander Marx

2 joint publications

Philipp Ströbel

2 joint publications

Tatsuo Furuya